Jacques Izopet

34.4k total citations · 7 hit papers
530 papers, 22.3k citations indexed

About

Jacques Izopet is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jacques Izopet has authored 530 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 307 papers in Hepatology, 280 papers in Infectious Diseases and 190 papers in Epidemiology. Recurrent topics in Jacques Izopet's work include Hepatitis Viruses Studies and Epidemiology (171 papers), Hepatitis C virus research (158 papers) and Liver Disease and Transplantation (138 papers). Jacques Izopet is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (171 papers), Hepatitis C virus research (158 papers) and Liver Disease and Transplantation (138 papers). Jacques Izopet collaborates with scholars based in France, United States and United Kingdom. Jacques Izopet's co-authors include Nassim Kamar, Florence Abravanel, Lionel Rostaing, Jean‐Michel Mansuy, Karine Sauné, Harry R. Dalton, Sébastien Lhomme, Christophe Pasquier, Martine Dubois and Jean‐Marie Péron and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Jacques Izopet

520 papers receiving 21.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients

2008 965 citations Nassim Kamar, Jean‐Michel Mansuy et al. profile →
Hepatitis E

2012 675 citations Nassim Kamar, Florence Abravanel et al. profile →
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

2021 510 citations Nassim Kamar, Florence Abravanel et al. profile →
Hepatitis E Virus Infection

2014 483 citations Nassim Kamar, Florence Abravanel et al. profile →
Hepatitis E virus infection

2017 396 citations Nassim Kamar, Jacques Izopet et al. profile →
Insertions and Duplications in the Polyproline Region of the Hepatitis E Virus

2020 353 citations Sébastien Lhomme, Florence Nicot et al. profile →
Proposed reference sequences for hepatitis E virus subtypes

2016 321 citations Jacques Izopet et al. profile →

Peers

Countries citing papers authored by Jacques Izopet

Since Specialization

Citations

This map shows the geographic impact of Jacques Izopet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Izopet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Izopet more than expected).

Fields of papers citing papers by Jacques Izopet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Izopet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Izopet. The network helps show where Jacques Izopet may publish in the future.

Co-authorship network of co-authors of Jacques Izopet

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Izopet. A scholar is included among the top collaborators of Jacques Izopet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Izopet. Jacques Izopet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HPV genotyping in clinical samples using long‐read single‐molecule real‐time sequencing 2024 ·Journal of Medical Virology ·Christophe Pasquier, Stéphanie Raymond, Romain Carcenac, (unknown), (unknown), Florence Nicot, Jacques Izopet	2
2	Comparison of short‐read and long‐read next‐generation sequencing technologies for determining HIV‐1 drug resistance 2024 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), Stéphanie Raymond, Nicolas Jeanne, (unknown), (unknown), (unknown), Dimitri Gonzalez, Pierre Delobel, Jacques Izopet	1
3	BK Viremia and Viruria Does Not Depend on the Type of Double-J Stent Used During Kidney Transplantation. 2024 ·Experimental and Clinical Transplantation ·Thomas Prudhomme, Chloé Couat, (unknown), Arnaud Del Bello, Karine Sauné, Jacques Izopet, M. Soulié, F. Sallusto, Nassim Kamar	1
4	Effect of steroid pulses in severe BK virus allograft nephropathy with extensive interstitial inflammation 2024 ·Transplant Infectious Disease ·(unknown), Arnaud Del Bello, F. Sallusto, Audrey Delas, Magali Colombat, Jean‐Michel Mansuy, Jacques Izopet, Nassim Kamar, Julie Bellière	1
5	Weaker Effects of the Fourth Dose of BNT162b2 SARS-CoV-2 Vaccine on the Elderly Human Population 2023 ·Vaccines ·Chloé Dimeglio, (unknown), (unknown), (unknown), (unknown), Pauline Trémeaux, Hélène Villars, Jacques Izopet	1
6	Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro 2022 ·Viruses ·(unknown), Hélène Martin, Yann Aubert, Jean‐Michel Mansuy, Marlène Marcellin, Odile Burlet‐Schiltz, Ilse Hurbain, Graça Raposo, Jacques Izopet, Thierry Fournier, Alexandra Benchoua, Mélinda Bénard, (unknown), Géraldine Cartron, (unknown), Nathalie Moinard, Gisela D’Angelo, Cécile E. Malnou	6
7	Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients 2022 ·Viruses ·Nassim Kamar, Arnaud Del Bello, Florence Abravanel, Qiuwei Pan, Jacques Izopet	4
8	Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants 2021 ·Annals of Internal Medicine ·Olivier Marion, Arnaud Del Bello, Florence Abravanel, Chloé Couat, Stanislas Faguer, Laure Esposito, Anne Laure Hébral, Jacques Izopet, Nassim Kamar	92
9	No evidence of occult hepatitis C or E virus infections in liver‐transplant patients with sustained virological response after therapy with direct acting agents 2019 ·Transplant Infectious Disease ·Arnaud Del Bello, Florence Abravanel, Laurent Alric, Laurence Lavayssière, Sébastien Lhomme, Julie Bellière, Jacques Izopet, Nassim Kamar	4
10	Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation 2018 ·Transplant Infectious Disease ·(unknown), Hans H. Hirsch, Catherine Mengelle, Laure Esposito, Anne Laure Hébral, Julie Bellière, (unknown), Jacques Izopet, Arnaud Del Bello, Nassim Kamar	16
11	Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies 2018 ·Clinical Infectious Diseases ·Sidonie Lambert-Niclot, (unknown), Jean‐Luc Meynard, Anne‐Geneviève Marcelin, Marc‐Antoine Valantin, Philippe Flandre, Jacques Izopet, Laëtitia Moinot, Vincent Bouteloup, Vincent Cálvez, Christine Katlama, Pierre‐Marie Girard, Laurence Morand‐Joubert	3
12	Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein 2018 ·Journal of Hepatology ·(unknown), Czeslaw Wychowski, Ibrahim M. Sayed, Jean‐Christophe Meunier, Jean‐Michel Saliou, Maliki Ankavay, A W Bull, André Pillez, Florence Abravanel, (unknown), Étienne Brochot, Hervé Drobecq, (unknown), Cécile‐Marie Aliouat‐Denis, Juliano G. Haddad, Jacques Izopet, Philip Meuleman, Anne Goffard, Jean Dubuisson, Laurence Cocquerel	4
13	Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver 2016 ·Gut ·Ibrahim M. Sayed, Lieven Verhoye, Laurence Cocquerel, Florence Abravanel, Lander Foquet, (unknown), Yannick Debing, Ali Farhoudi, Czeslaw Wychowski, Jean Dubuisson, Geert Leroux‐Roels, Johan Neyts, Jacques Izopet, Thomas Michiels, Philip Meuleman	106
14	HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway 2015 ·PLoS ONE ·(unknown), Rémi Planès, Kaoutar Leghmari, (unknown), Pierre Delobel, Jacques Izopet, Lbachir BenMohamed, Elmostafa Bahraoui	59
15	Tenofovir Therapy in Hepatitis B Virus-Positive Solid-Organ Transplant Recipients 2011 ·Transplantation ·(unknown), Lionel Rostaing, Karine Sauné, Laurence Lavayssière, G. Basse, Laure Esposito, Joëlle Guitard, Jacques Izopet, Laurent Alric, Nassim Kamar	32
16	L’hépatite E chronique 2009 ·Virologie ·Jacques Izopet, Nassim Kamar, Florence Abravanel, Martine Dubois, Sébastien Lhomme, Jean‐Michel Mansuy, Laurent Alric, Jean‐Marie Péron, Lionel Rostaing	0
17	Recombinaison génétique et virus de l’hépatite C 2008 ·Virologie ·Florence Abravanel, Jacques Izopet	1
18	[Hepatitis C infection among patients receiving hemodialysis]. 2003 ·PubMed ·Nassim Kamar, Jacques Izopet, Lionel Rostaing	5
19	Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study 2001 ·AIDS ·Diane Descamps, Vincent Cálvez, Jacques Izopet, Claudine Buffet‐Janvresse, (unknown), Philippe Colson, Annick Ruffault, Anne Maillard, Bernard Masquelier, Jacqueline Cottalorda, M Harzic, Françoise Brun‐Vézinet, Dominique Costagliola	30
20	Infections nosocomiales à VHC en hémodialyse 2001 ·Annales de biologie clinique ·Jacques Izopet, Karine Sauné, G. Salama, Christophe Pasquier, Jean‐Luc Puel, Lionel Rostaing	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact